Following publications arose from collaboration with other scientific groups. (
Tyto publikace vznikly ve spolupráci s dalšími vědeckými skupinami).
- Vlčková HK, Catapano MC, Mitašík L, Kotland O, Nejmanová I, Pourová J, Mladěnka P & Nováková L. Featuring ultimate sensitivity of high resolution LC-MS analysis of phenolics in rat plasma. J Sep Sci 2021;44(9): 1893-1903 /IF2019 2.8/
- Tvrdý V, Pourová J, Jirkovský E, Křen V, Valentová K & Mladěnka P. Systematic review of pharmacokinetics and potential pharmacokinetic interactions of flavonolignans from silymarin. Med Res Rev 2021; 41:2195–2246 /IF2019 9.3/
- Najmanová I, Vopršalová M, Saso L & Mladěnka P. The pharmacokinetics of flavanones. Crit Rev Food Sci Nutr 2020; 60(18): 3155-3171 /IF2018=6.7/
- Pilařová V, Plachká K, Chrenková L, Najmanová I, Mladěnka P, Švec F, Novák O & Nováková L. Simultaneous determination of quercetin and its metabolites in rat plasma by using ultra-high performance liquid chromatography tandem mass spectrometry. Talanta 2018,185: 71-79 /IF2016=4.2/
- Porcu EP, Cossu M, Rassu G, Giunchedi P, Cerri G, Pourová J, Najmanová I, Migkos T, Pilařová V, Nováková L, Mladěnka P & Gavini E. Aqueous injection of quercetin: an approach for confirmation of its direct in vivo cardiovascular effects. Int J Pharmaceut 2018; 541(1-2):224-233 /IF2016=3.6/
- Bureš J, Jansová H, Stariat J, Filipský T, Mladěnka P, Šimůnek T, Kučera R, Klimeš J, Wang Q, Franz KJ, Kovaříková P. LC-UV/MS methods for the analysis of prochelator-Boronyl salicylaldehyde isonicotinoyl hydrazone (BSIH) and its active chelator salicylaldehyde isonicotinoyl hydrazone (SIH). J Pharm Biomed Anal. 2014;105C:55-63 /IF2013=2.8/
- Říha M, Vopršalová M, Pilařová V, Semecký V, Holečková M, Vávrová J, Palicka V, Filipský T, Hrdina R, Nováková L & Mladěnka P. Oral administration of quercetin is unable to protect against isoproterenol cardiotoxicity. Naunyn Schmiedebergs Arch Pharmacol 2014;in press /IF2012=2.1/
- Stariat J, Suprunová V, Roh J, Sesták V, Eisner T, Filipský T, Mladěnka P, Nobilis M, Šimůnek T, Klimeš J, Kalinowski DS, Richardson DR, Kovaříková P. Simultaneous determination of the novel thiosemicarbazone anti-cancer agent, Bp4eT, and its main phase I metabolites in plasma: Application to a pilot pharmacokinetic study in rats. Biomed Chromatogr. 2014;28(5):621-9 /IF2012=1.9/
- Janůšová B, Školová B, Tükörová K, Wojnarová L, Šimůnek T, Mladěnka P, Filipský T, Říha M, Roh J, Palát K, Hrabálek A, Vávrová K. Amino acid derivatives as transdermal permeation enhancers. J Control Release 2013; 165(2):91-100 /IF2011=6.5/